Catalent has appointed Ricardo Zayas as Senior Vice President, Operations, Biologics North America.
Zayas will be responsible for all of the company’s North American biologics operations, including its centers of excellence for drug product fill/finish in Bloomington, Indiana, and gene therapy manufacturing in Harmans, Maryland.
He will also serve on the Executive Leadership Team, reporting directly to Catalent’s President & Chief Executive Officer, Alessandro Maselli.
Mr. Zayas’ experience includes more than 30 years working in pharmaceutical manufacturing and operations leadership. He joins Catalent from Ocyonbio, a biosimilars, cell and gene, and viral vector development and manufacturing company, where he was Chief Operating Officer.
Prior to that, as Executive Vice President and Head of Operations for Romark Pharmaceuticals, he led the development and buildout of Romark’s new manufacturing facility in Puerto Rico.
His career also includes seven years at Bristol-Myers Squibb, where he held the position of Senior Vice President, Global Pharmaceutical Manufacturing, Supply Chain, and Product Strategy, and led global pharmaceutical and API manufacturing, overseeing more than 8,000 employees worldwide.
He has also held pharmaceutical manufacturing leadership roles at Sterling Drug, Warner-Lambert, Pfizer, Schering Plough, AMAG Pharmaceuticals, and Avon Products.
He holds a bachelor’s degree in industrial engineering from Kansas State University, Manhattan, Kansas.